AbbVie

Open: 153.0 Close: 153.42 Change: 0.42

Don't invest in AbbVie before reading this automated analysis produce by an AI.

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, market, price, research, analyst, announce, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie announced the acquisition of Cerevel Therapeutics in $8.7 billion all-cash deal. Q4 earnings are confirmed for Thursday, February 8, 2024. There is no upcoming split.

Today's News

8 analysts have this to say about abbvie | markets insider. AbbVie announced the acquisition of Cerevel Therapeutics. AbbVie is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers. In 2022, Abbvie revenue was $58.05 billion. AbbVie has announced its acquisition of ImmunoGen for $10.1 billion in cash, marking a strategic move amidst rising competition for their leading treatment, Humira. AbbVie to pay $10.1 billion for drugmaker immunogen (correct) Abbvie shares fell 0.4%. According to 8 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $174.5 with a high of $196.00 and a low of $150.00. As of December 2023 Abbvie has a market cap of $270 billion. AbbVie plans more Phase III studies with cancer drug epcoritamab for the treatment of lymphoma during 2024. The drug is on the market under the name Epkinly/Tepkinly. The Development Sciences Automation lead is responsible for planning, coordinating, developing, and implementing automation projects in a high quality manner. AbbVie stock price, news, charts, stock profile, research, research and research profile. Abbvie to buy Cerevel Therapeutics in $8.7 billion all-cash deal. AbbVie (ABBV) is in the Health Care sector and Biotechnology industry. Q4 earnings are confirmed for Thursday, February 8, 2024. There is no upcoming split.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, market, price, research, analyst, announce, and the most common words in the summary are: abbvie, stock, job, market, news, price, abbv, . One of the sentences in the summary was: Q4 earnings are confirmed for Thursday, February 8, 2024. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #job #market #news #price #abbv.